Skip to main content
Have a personal or library account? Click to login
Understanding Undergraduate Medicines Optimisation Education and Its Importance; a Realist Evaluation Cover

Understanding Undergraduate Medicines Optimisation Education and Its Importance; a Realist Evaluation

Open Access
|Aug 2026

References

  1. Ridge K. Good for you, good for us, good for everybody: a plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions. In: Care DoHaS, editor, GOV.UK; 2021.
  2. Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. European journal of internal medicine. 2017;38:311. DOI: 10.1016/j.ejim.2016.12.021
  3. Salisbury C, Man M-S, Bower P, Guthrie B, Chaplin K, Gaunt DM, et al. Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach. The Lancet. 2018;392(10141):4150. DOI: 10.1016/S0140-6736(18)31308-4
  4. Payne R, Duerden M. Polypharmacy – appropriate, problematic or both? Prescriber. 2015;26(4):3134. DOI: 10.1002/psb.1313
  5. Reeve J, Maden M, Hill R, Turk A, Mahtani K, Wong G, et al. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis. Health Technology Assessment. 2022;26(32):1148. DOI: 10.3310/AAFO2475
  6. Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation. Making it safe and sound. London: The King’s Fund; 2013.
  7. Bansal A, Greenley S, Mitchell C, Park S, Shearn K, Reeve J. Optimising planned medical education strategies to develop learners’ person-centredness: A realist review. Medical Education. 2022;56(5):489503. DOI: 10.1111/medu.14707
  8. Bodington R, Reeve J, Hepburn D, Morgan M, Crampton PE. Teaching routine person-centred practice in medical education through medicines optimisation: A realist review. Medical Education. 2025. DOI: 10.1111/medu.15727
  9. Medicines optimisation Quality standard [QS120]. National Institute for Health and Care Excellence (NICE); 2016.
  10. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. National Institute for Health and Care Excellence (NICE); 2015.
  11. Barnett N, Jubraj B, Grant D, Reddy B, Stevenson JM. Medication review, polypharmacy and deprescribing: Results of a pilot scoping exercise in undergraduate and postgraduate education. Pharmacy Education. 2021;21(1):126132. DOI: 10.46542/pe.2021.211.126132
  12. Jubraj B, Marvin V, Poots AJ, Patel S, Bovill I, Barnett N, et al. A pilot survey of junior doctors’ attitudes and awareness around medication review: time to change our educational approach? European Journal of Hospital Pharmacy Science & Practice. 2015;22(4):243248. DOI: 10.1136/ejhpharm-2015-000664
  13. Poots AJ, Jubraj B, Ward E, Wycoco A, Barnett N. Education around medication review and deprescribing: a survey of medical and pharmacy students’ perspectives. Therapeutic Advances in Drug Safety. 2020;11:2042098620909610. DOI: 10.1177/2042098620909610
  14. Wong G, Westhorp G, Manzano A, Greenhalgh J, Jagosh J, Greenhalgh T. RAMESES II reporting standards for realist evaluations. BMC medicine. 2016;14(1):118. DOI: 10.1186/s12916-016-0643-1
  15. Wong G, Westhorp G, Greenhalgh J, Manzano A, Jagosh J, Greenhalgh T. Quality and reporting standards, resources, training materials and information for realist evaluation: the RAMESES II project. Health Services and Delivery Research. 2017;5(28). DOI: 10.3310/hsdr05280
  16. Pawson R. Evidence-Based Policy: A Realist Perspective. London: Sage; 2006. DOI: 10.4135/9781849209120
  17. Brennan N, Mattick K. A systematic review of educational interventions to change behaviour of prescribers in hospital settings, with a particular emphasis on new prescribers. British Journal of Clinical Pharmacology. 2013;75(2):359372. DOI: 10.1111/j.1365-2125.2012.04397.x
  18. Tilley N, Pawson R, editors. Realistic evaluation: an overview. founding conference of the Danish Evaluation Society; 2000.
  19. Reeve J. Medical Generalism, Now! Reclaiming the Knowledge Work of Modern Practice. 1st ed. Milton: Taylor & Francis Group; 2023. DOI: 10.1201/9781003297222-1
  20. Howe A. What’s special about medical generalism? The RCGP’s response to the independent Commission on Generalism. British Journal of General Practice. 2012;342343. DOI: 10.3399/bjgp12X652175
  21. Reeve J. Interpretive medicine: supporting generalism in a changing primary care world. Occasional Paper (Royal College of General Practitioners). 2010(88):1.
  22. Wong G, Westhorp G, Pawson R, Greenhalgh T. Realist synthesis. RAMESES training materials. London: The RAMESES Project; 2013.
  23. Jagosh J, Stott H, Halls S, Thomas R, Liddiard C, Cupples M, et al. Benefits of realist evaluation for rapidly changing health service delivery. BMJ Open. 2022;12(7):e060347. DOI: 10.1136/bmjopen-2021-060347
  24. Pawson R, Tilley N. Realistic Evaluation. London: Sage; 1997.
  25. Pawson R. The Science of Evaluation: A Realist Manifesto. London: Sage; 2013. DOI: 10.4135/9781473913820
  26. Manzano A. The craft of interviewing in realist evaluation. Evaluation. 2016;22(3):342360. DOI: 10.1177/1356389016638615
  27. Mukumbang FC, Marchal B, Van Belle S, van Wyk B. Using the realist interview approach to maintain theoretical awareness in realist studies. Qualitative Research. 2020;20(4):485515. DOI: 10.1177/1468794119881985
  28. Rees CE, Davis C, Nguyen VN, Proctor D, Mattick KL. A roadmap to realist interviews in health professions education research: Recommendations based on a critical analysis. Medical Education; 2023. DOI: 10.1111/medu.15270
  29. Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qualitative health research. 2016;26(13):17531760. DOI: 10.1177/1049732315617444
  30. Greenhalgh T, Pawson R, Wong G, Westhorp G, Greenhalgh J, Manzano A, Jagosh J. Philosophies and evaluation design: The RAMESES II Project. University of Oxford; 2017.
  31. Gilmore B, McAuliffe E, Power J, Vallières F. Data Analysis and Synthesis Within a Realist Evaluation: Toward More Transparent Methodological Approaches. International Journal of Qualitative Methods. 2019;18:1609406919859754. DOI: 10.1177/1609406919859754
  32. McCarthy M. Experiential learning theory: From theory to practice. Journal of Business & Economics Research (JBER). 2016;14(3):91100. DOI: 10.19030/jber.v14i3.9749
  33. Dirkx JM. Transformative learning theory in the practice of adult education: An overview. PAACE journal of lifelong learning. 1998;7:114.
  34. Downey J, Harris N, Rybczynska-Bunt S, Golder E, Shearn K, Bradley N. Reflecting on Reflexivity in Realist Evaluation: A Call to Action. International Journal of Qualitative Methods. 2024;23:16094069241284206. DOI: 10.1177/16094069241284206
  35. McCahon D, Denholm RE, Huntley AL, Dawson S, Duncan P, Payne RA. Development of a model of medication review for use in clinical practice: Bristol medication review model. BMC medicine. 2021;19:110. DOI: 10.1186/s12916-021-02136-9
  36. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2023;71(7):20522081. DOI: 10.1111/jgs.18372
  37. Sallevelt B, Egberts TCG, Huibers CJA, Ietswaart J, Drenth-van Maanen AC, Jennings E, et al. Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission. Drug Safety. 2022;45(12):15011516. DOI: 10.1007/s40264-022-01237-5
  38. Cruess RL, Cruess SR, Steinert Y. Amending Miller’s pyramid to include professional identity formation. Academic Medicine. 2016;91(2):180185. DOI: 10.1097/ACM.0000000000000913
  39. Raman-Wilms L, Farrell B, Sadowski C, Austin Z. Deprescribing: An educational imperative. Research In Social & Administrative Pharmacy. 2019;15(6):790795. DOI: 10.1016/j.sapharm.2018.08.011
  40. Gabbay J, Le May A. Practice-based evidence for healthcare: clinical mindlines. Routledge; 2010. DOI: 10.4324/9780203839973
  41. Barnett N, Minshull J, Algebory M, Dave K, Jhingan M, Kalsi D, et al. The Scottish Polypharmacy Guidance app in practice. Prescriber. 2020;31(6):1013. DOI: 10.1002/psb.1847
  42. Farrell B, Raman-Wilms L, Sadowski CA, Mallery L, Turner J, Gagnon C, et al. A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing. Medical Science Educator. 2023;33(2):551567. DOI: 10.1007/s40670-022-01704-9
  43. Shinfuku N. Analysis of the trends of polypharmacy and high-dose prescriptions in Japan. Asia-Pacific Psychiatry. 2022;14(1). DOI: 10.1111/appy.12488
  44. Huang CY, Wu MY, Chang CL, Liao YC, Chen YY, Lin WC, Yen HR. Coprescription Trends in Western Medicine, Chinese Herbal Medicine and Dental Medicine among Older Adults in Taiwan from 1997 to 2013. Complementary Therapies in Medicine. 2021;63. DOI: 10.1016/j.ctim.2021.102782
  45. Vos R, Boesten J, van den Akker M. Fifteen-year trajectories of multimorbidity and polypharmacy in Dutch primary care-A longitudinal analysis of age and sex patterns. Plos One. 2022;17(2). DOI: 10.1371/journal.pone.0264343
  46. Zhang NQ, Sundquist J, Sundquist K, Ji JG. An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study. Frontiers in Pharmacology. 2020;11. DOI: 10.3389/fphar.2020.00326
  47. Wang XW, Liu KY, Shirai K, Tang CY, Hu YH, Wang Y, et al. Prevalence and trends of polypharmacy in US adults, 1999–2018. Global Health Research and Policy. 2023;8(1). DOI: 10.1186/s41256-023-00311-4
  48. Cernasev A, Scott D, Barenie R, Walker C, Khan M, Koltnow P, et al. “I think deprescribing is very needed in our society:” Healthcare Professional Students Perceptions of Deprescribing Education. Innov Pharm. 2024;15(3). DOI: 10.24926/iip.v15i3.5948
  49. Turk A, Wong G, Mahtani KR, Maden M, Hill R, Ranson E, et al. Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review. BMC medicine. 2022;20(1):297. DOI: 10.1186/s12916-022-02475-1
  50. Sadowski CA, Farrell B, Raman-Wilms L, Mallery L, Gagnon C, Turner J. A curriculum framework for an interprofessional approach to deprescribing. Journal of the American Geriatrics Society. 2023;71(Supplement 1):S59. DOI: 10.1016/j.ajpe.2023.100267
  51. Donker E, Piët JD, Rychlíčková J, Cazaubon Y, De Ponti F, Tichelaar J. Unified by Diversity: Insights into Pharmacotherapy Education Through an International and Interprofessional Student-Run Clinic; 2024.
  52. Sultan R, van den Beukel TO, Reumerman MO, Daelmans HEM, Springer H, Grijmans E, et al. An Interprofessional Student-Run Medication Review Program: The Clinical STOPP/START-Based Outcomes of a Controlled Clinical Trial in a Geriatric Outpatient Clinic. Clinical Pharmacology and Therapeutics. 2022;111(4):931938. DOI: 10.1002/cpt.2475
  53. Reumerman MO, Richir MC, Domela Nieuwenhuis PM, Sultan R, Daelmans HEM, Springer H, et al. The clinical and educational outcomes of an inter-professional student-led medication review team, a pilot study. European Journal of Clinical Pharmacology. 2021;77(1):117123. DOI: 10.1007/s00228-020-02972-3
  54. Schutte T, Tichelaar J, Dekker RS, van Agtmael MA, de Vries TP, Richir MC. Learning in student-run clinics: A systematic review. Medical education. 2015;49(3):249263. DOI: 10.1111/medu.12625
  55. Dekker RS, Schutte T, Tichelaar J, Thijs A, van Agtmael MA, de Vries TP, Richir MC. A novel approach to teaching pharmacotherapeutics—feasibility of the learner-centered student-run clinic. European journal of clinical pharmacology. 2015;71:13811387. DOI: 10.1007/s00228-015-1916-x
  56. Reinders JJ, Başer Kolcu M, Kolcu G. Developing an interprofessional identity complementary to a professional identity – findings related to Extended Professional Identity Theory (EPIT). Front Med (Lausanne). 2024;11:1467362. DOI: 10.3389/fmed.2024.1467362
  57. Reinders J-J. When I Say … Interprofessional identity. Medical Education. 2026;60(3):224226. DOI: 10.1111/medu.70027
  58. Hobbs AM, Plummer L. Interprofessional Identity Formation. J Phys Ther Educ. 2025;39(3):296297. DOI: 10.1097/JTE.0000000000000418
  59. Tong R, Brewer M, Flavell H, Roberts LD. Professional and interprofessional identities: a scoping review. Journal of Interprofessional Care. 2025;39(5):848856. DOI: 10.1080/13561820.2020.1713063
  60. The Future Doctor Programme. A co-created vision for the future clinical team. Health Education England; 2020.
  61. Kallis TJ, Mattick K, Scott J, Payne RA. How do pharmacists navigate clinical uncertainty when reviewing polypharmacy? A critical literature review. BMC Primary Care. 2025;26(1):412. DOI: 10.1186/s12875-025-03122-3
DOI: https://doi.org/10.5334/pme.2450 | Journal eISSN: 2212-277X
Language: English
Page range: 647 - 662
Submitted on: Jan 29, 2026
Accepted on: Jun 15, 2026
Published on: Aug 25, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services

© 2026 Richard Bodington, Joanne Reeve, David Hepburn, Matthew Morgan, Paul E. S. Crampton, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.